RESECTED LYMPH NODES AND SURVIVAL OF PATIENTS WITH ESOPHAGEAL SQUAMOUS CELL CARCINOMA: AN OBSERVATIONAL STUDY

NCT ID: NCT05570487

Last Updated: 2022-10-25

Basic Information

• Recruitment Status: UNKNOWN
• Total Enrollment: 1600 participants
• Study Classification: OBSERVATIONAL
• Study Start Date: 2022-10-01
• Study Completion Date: 2023-10-01

Brief Summary

To clarify the effect of the number of lymph node dissection and the number of stations on survival

Conditions

the Records of Esophageal Cancer

Study Design

• Observational Model Type: CASE_ONLY
• Study Time Perspective: RETROSPECTIVE

Study Groups

N0A Group

patients with negative lymph nodes and resected lymph nodes less than 15

Since the data were collected retrospectively, there were no interventions

Intervention Type: DIAGNOSTIC_TEST

Since the data were collected retrospectively, there were no interventions

N0B Group

patients with negative lymph nodes and resected lymph nodes no less than 15

Since the data were collected retrospectively, there were no interventions

Intervention Type: DIAGNOSTIC_TEST

Since the data were collected retrospectively, there were no interventions

N+A Group

patients with positive lymph nodes and resected lymph nodes less than 15

Since the data were collected retrospectively, there were no interventions

Intervention Type: DIAGNOSTIC_TEST

Since the data were collected retrospectively, there were no interventions

N+B Group

patients with positive lymph nodes and resected lymph nodes no less than 15

Since the data were collected retrospectively, there were no interventions

Intervention Type: DIAGNOSTIC_TEST

Since the data were collected retrospectively, there were no interventions

Interventions

Since the data were collected retrospectively, there were no interventions

Since the data were collected retrospectively, there were no interventions

Intervention Type: DIAGNOSTIC_TEST

Eligibility Criteria

Inclusion Criteria

1. Men and women aged 18-85;

2. Histologically confirmed primary thoracic esophageal squamous cell carcinoma,

3. Staging PT1-4A, N0-3, M0 AJCC eighth edition;

4. Excluding lymph node dissection < 15,(meeting the guideline criteria)

Exclusion Criteria

1. Patients with a history of previous thoracic and abdominal surgery that may affect lymphatic reflux

2. Patients with distant metastasis confirmed by imaging;

3. Patients with obvious surgical contraindications.

• Minimum Eligible Age: 18 Years
• Maximum Eligible Age: 90 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

Yongtao Han

OTHER

Sponsor Role: lead

Responsible Party

Yongtao Han

Clinical Professor

Responsibility Role: SPONSOR_INVESTIGATOR

Locations

Sichuan Cancer Hospital

Chengdu, Sichuan, China

Site Status: RECRUITING

Countries

China

Facility Contacts

Yongtao Han

Role: primary

doc.leng@uestc.edu.cn

+8618702870755

References

Li K, Leng X, Peng L. Resected lymph nodes and survival of patients with esophageal squamous cell carcinoma in pT2 and pT3. Int J Surg. 2024 Mar 1;110(3):1879-1881. doi: 10.1097/JS9.0000000000001023. No abstract available.

Reference Type: DERIVED

PMID: 38116658 (View on PubMed)

Li K, Leng X, He W, Du K, Li C, Liu K, Wang C, Liu G, Li Z, Jiang L, Li K, Zhou Q, Li J, Luo X, Nie X, Lu S, Li H, Fang Q, Xiao W, Han Y, Peng L. Resected lymph nodes and survival of patients with esophageal squamous cell carcinoma: an observational study. Int J Surg. 2023 Jul 1;109(7):2001-2009. doi: 10.1097/JS9.0000000000000436.

Reference Type: DERIVED

PMID: 37222685 (View on PubMed)

Other Identifiers

SichuanCHRIA

Identifier Type: -

Identifier Source: org_study_id